Clinical Trials Logo
  1. Home
  2. Sugammadex
  3. NCT06081738

Neostigmine Versus Sugammadex on Renal Functions

Sugammadex Clinical Trial

Official title:
Evaluation of The Effects of Neostigmine Versus Sugammadex on Renal Functions in Laparoscopic Cholecystecomy A Randomized Controlled Study

Clinical Trial Summary

The study will assess the acute effects of sugammadex or neostigmine on renal function as determined with more specific and sensitive tests in laparoscopic cholecystectomy

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06081738
Study type Interventional
Source Menoufia University
Contact
Status Active, not recruiting
Phase Phase 4
Start date March 1, 2023
Completion date December 31, 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04997759 - Comparative Efficacy and Safety of Sugammadex and Neostigmine N/A
Recruiting NCT05794503 - Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Early Phase 1
Not yet recruiting NCT05751603 - Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex N/A
Completed NCT05066035 - Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine Phase 4
Completed NCT04471376 - The Effect of Sugammadex During Transcranial Electrical Motor Evoked Potential Monitoring in Spinal Surgery N/A
Recruiting NCT05028088 - Diaphragm Ultrasound to Evaluate the Antagonistic Effect of Sugammadex Phase 4
Recruiting NCT05886218 - Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
Completed NCT04332627 - Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine Phase 4
Completed NCT04608682 - Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording N/A
Recruiting NCT04566796 - Effectiveness of Sugammadex on Muscle Relaxant Reversal in Preterm Neonates N/A